Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia. (September 2022)

• Record Type: Journal Article
• Authors: Qi, Kunming; Hu, Xueting; Yu, Xiangru; Cheng, Hai; Wang, Chunqing; Wang, Shujin; Wang, Ying; Li, Yanjie; Cao, Jiang; Pan, Bin; Wu, Qingyun; Qiao, Jianlin; Zeng, Lingyu; Li, Zhenyu; Xu, Kailin; Fu, Chunling
• Is Part Of: Leukemia research. Volume 120(2022)
• Publication Date: 2022-09
• Subjects: Acute megakaryoblastic leukemia -- CDK4/6 inhibitors -- Cell proliferation -- Cell differentiation -- Apoptosis -- Mouse survival; Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2022.106920
• Languages: English
• ISSNs: 0145-2126

Abstract

Abstract: Acute megakaryoblastic leukaemia (AMKL) is characterized by expansion of megakaryoblasts, which are hyper-proliferative cells that fail to undergo differentiation. Insight to the cell-cycle regulation revealed important events in early or late megakaryocytes (MKs) maturation; the cyclin-dependent kinases 4 and 6 (CDK4/6) have been reported to participate in the development of progenitor megakaryocytes, mainly by promoting cell cycle progression and DNA polyploidization. However, it remains unclear whether the continuous proliferation, but not differentiation, of megakaryoblasts is related to an aberrant regulation of CDK4/6 in AMKL. Here, we found that CDK4/6 were up regulated in patients with AMKL, and persistently maintained at a high level during the differentiation of abnormal megakaryocytes in vitro, according to a database and western blot. Additionally, AMKL cells were exceptionally reliant on the cell cycle regulators CDK4 or 6, as blocking their activity using an inhibitor or short hairpin RNA (shRNA) significantly reduced the proliferation of 6133/MPL megakaryocytes, reduced DNA polyploidy, induced apoptosis, decreased the level of phosphorylated retinoblastoma protein (p-Rb), and activation of caspase 3. Additionally, CDK4/6 inhibitors and shRNA reduced the numbers of leukemia cells in the liver and bone marrow (BM), alleviated hepatosplenomegaly, and prolonged the survival of AMKL-transplanted mice. These results suggested that blocking the activity of CDK4/6 may represent an effective approach to control megakaryoblasts in AMKL. Highlights: The CDK4 or 6 was up regulated in AMKL patients, and maintained a high level in abnormal megakaryocytes Blocking CDK4 or 6 reduced the proliferation of 6133/MPL megakaryocytes, the DNA content, and induced apoptosis Inhibition of CDK4 or 6 alleviated hepatosplenomegaly and prolonged the survival of AMKL transplanted mice.